X4 Pharmaceuticals (XFOR) Share-based Compensation (QoQ) (2017 - 2025)
X4 Pharmaceuticals (XFOR) Share-based Compensation (QoQ) (2017 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - |
| 2 | Nanobiotix | 1,910.87 Bn | 1,910.81 Bn | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.14 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - |
| 8 | Argenx Se | 55.83 Bn | 50.65 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.46 Bn | 37.46 Bn | - |
| 10 | X4 Pharmaceuticals | 167.48 Mn | -49.57 Mn | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 198.82% |
| Sep 30, 2025 | 1.60% |
| Jun 30, 2025 | 44.12% |
| Mar 31, 2025 | -76.59% |
| Dec 31, 2024 | 21.81% |
| Sep 30, 2024 | -25.04% |
| Jun 30, 2024 | 39.62% |
| Mar 31, 2024 | -31.51% |
| Dec 31, 2023 | 7.54% |
| Sep 30, 2023 | 10.22% |
| Jun 30, 2023 | 30.21% |
| Mar 31, 2023 | -68.29% |
| Dec 31, 2022 | 274.71% |
| Sep 30, 2022 | -200.00% |
| Jun 30, 2022 | 24,641.67% |
| Mar 31, 2022 | -99.25% |
| Dec 31, 2021 | 6.13% |
| Sep 30, 2021 | -50.38% |
| Dec 31, 2020 | -65.19% |
| Sep 30, 2020 | 770.45% |